Placenta derived mesenchymal stem cell or neural progenitor induced from placenta derived stem cell and pharmaceutical composition treatment kit and treatment method comprising the same

摘要

The present invention relates to a neural progenitor cell derived from placenta-derived mesenchymal stem cells or placenta-derived stem cells, a pharmaceutical composition containing the same, a kit for treating a disease, and a method for treating a disease using the same. Specifically, when the stem cells of the present invention are used, they can be effectively used for angiogenesis-related diseases such as neurological diseases such as Alzheimer's disease, Parkinson's disease, HIV dementia, epilepsy, cancer and retinopathy, and the industrial utilization is high.